pros and cons of glp-1 drugs The Surprising Truth About Nutrition Natural — Wellness Blog — Sundala Wellness Your guide to GLP-1 side

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

pooling data for lixisenatide (Adlyxin, Sanofi), liraglutide (Victoza,

Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors

This study highlighted the superiority of the patented Ginfort extract, which stands out due to its highly concentrated formula, improved solubility, and proven efficacy

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management

Berberine is an organic compound sourced from the roots, stems, leaves and barks of plants belonging to the genus, Berberis